Biotrial is participating in the 9th Neuropsychiatric Drug Development Summit at 15-17 September at Boston.
Published
Signal category
Presence & Recognition
Quote
“9th Neuropsychiatric Drug Development Summit (NDDS): 15-17 September, Boston”
— Biotrial team
Company
Biotrial
Contract Research Organization since 1989. Preclinical • Phase 1 • Patient Studies • Biometrics • Core Lab • Bioanalysis
- Industry
- Research Services
- Location
- Europe and North America, FR
- Company size
- 281 employees
As Global Provider in Early Development, we offer Non-Clinical, Clinical and Bioanalytical solutions for both pharmaceutical and biotech companies and we tailor our high-quality services to fit sponsors’ needs. Flexible and responsive, we use our efficient working practices to streamline the drug development process. With over 30 years of experience, we have established long-standing relationships with our sponsors – through the respect of deadlines and budget terms as well as rigorous quality control. Our medical and scientific teams get involved in projects from the very beginning, adding value and saving time by integrating their input into the trial design. Curious about how our solutions might help you to reach your milestones? Do not hesitate to contact us: contact@biotrial.com
Founded 1989